RxDoctor Payments DataLook up a doctor →

Asaad Samra, MD

Plastic Surgery · Holmdel, NJNPI 1285661793

Payments from drug & device makers

$223,807in general payments, 2019–2025

Across 313 payments — averaging $715.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Musculoskeletal Transplant Foundation Inc.$216K
  • Merz North America, Inc.$1K
  • RTI Surgical, Inc$1K
  • AbbVie$861
  • Sientra, Inc.$789
  • Mentor Worldwide LLC$721
  • plus $3K from 28 others
$12,068in research payments, 2019–2025

Across 7 payments — averaging $1723.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Musculoskeletal Transplant Foundation Inc.$12K

What the payments were for

  • Consulting fees$204,31491%
  • Speaking & faculty fees$1,2001%
  • Travel & lodging$6,1063%
  • Food & beverage$11,9965%
  • Gifts$1910%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$223,807 in reported general payments places this provider in the 95th percentile of 170 plastic surgery providers in New Jersey.

See all plastic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$707,147
Medicare patients
124
Services billed
642

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin23$160
Cefadroxil33$147
Ondansetron OdtOndansetron13$140
Gabapentin20$108
Ibuprofen23$74
Cyclobenzaprine Hcl15$25

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Holmdel

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →